NCT02976558

Brief Summary

The allogenic stem cell transplantation (aSCT), the only curative approach for many hematological diseases, often leads to severe diseases or chronic conditions, leaving patients with physical disabilities and severe depression and impacting their quality of life in many cases. These consequences are still not adequately addressed by conventional therapies. In this study, the investigators examine the influence of the three complementary medicine methods (CAM) namely acupuncture according to Traditional Chinese Medicine (TCM), music therapy according to the TaKeTiNa method and the psychological disease processing by theatrical clown performance on the quality of life and the therapy process of patients before and after aSCT.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
104

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 21, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 29, 2016

Completed
2 days until next milestone

Study Start

First participant enrolled

December 1, 2016

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 16, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 16, 2019

Completed
Last Updated

December 18, 2019

Status Verified

December 1, 2019

Enrollment Period

3 years

First QC Date

November 21, 2016

Last Update Submit

December 16, 2019

Conditions

Keywords

CAMallogenic Stem Cell TransplantationGraft-Versus-Host DiseaseDepressionQuality of LifeAcupunctureTraditional chinese MedicineIntegrative medicineComplementary and Alternative MedicineMusic therapy TaKeTiNaClown theatrical performanceHumourChemotherapy side effectsPsycho neuro immune systemGvHDPNEISCMVEBVholistic medicine

Outcome Measures

Primary Outcomes (1)

  • Difference in the Quality of Life of the intervention group compared to the control group

    Assessment through FACT-G Questionaire

    day 1 of study compared to day 90 of study

Secondary Outcomes (8)

  • Difference in development of GvHD of the intervention group compared to the control group

    day 1 of study compared to day 90 of study

  • Difference in development of fungal infections of the intervention group compared to the control group

    day 1 of study compared to day 90 of study

  • Difference in development of bacterial infections of the intervention group compared to the control group

    day 1 of study compared to day 90 of study

  • Difference in development of viral infections including CMV and EBV of the intervention group compared to the control group

    day 1 of study compared to day 90 of study

  • Difference in Depression of the intervention group compared to the control group

    day 1 of study compared to day 90 of study

  • +3 more secondary outcomes

Study Arms (2)

Treatment Group

EXPERIMENTAL

Interventions: Acupuncture, music therapy (TaKeTiNa) and Clown theatrical performance starting before allogenic stem cell transplant until three months after transplantation. Interventions each twice a week for 4 weeks, then once a week for 4 weeks, then once every two weeks for 4 weeks

Behavioral: Clown theatrical PerformanceProcedure: AcupunctureBehavioral: Music Therapy TaKeTiNa

Control Group

NO INTERVENTION

control group. No interventions

Interventions

Also known as: theatre therapy, humour for health
Treatment Group
AcupuncturePROCEDURE

Acupuncture according to Traditional Chinese Medicine

Treatment Group
Treatment Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • planned allogenic stem cell transplantation
  • patient mentally and intellectually able to understand and sign the form

You may not qualify if:

  • Current enrollment in another intervention study
  • clinical diagnosis of depression by HADS-D score plus drug therapy for depression at the time of enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Erlangen Nuermberg Medical School

Erlangen, Bavaria, 91054, Germany

Location

Related Publications (11)

  • Bacigalupo A, Sormani MP, Lamparelli T, Gualandi F, Occhini D, Bregante S, Raiola AM, di Grazia C, Dominietto A, Tedone E, Piaggio G, Podesta M, Bruno B, Oneto R, Lombardi A, Frassoni F, Rolla D, Rollandi G, Viscoli C, Ferro C, Garbarino L, Van Lint MT. Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation. Haematologica. 2004 Oct;89(10):1238-47.

    PMID: 15477210BACKGROUND
  • Blazar BR, Murphy WJ, Abedi M. Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol. 2012 May 11;12(6):443-58. doi: 10.1038/nri3212.

    PMID: 22576252BACKGROUND
  • Braamse AM, Yi JC, Visser OJ, Heymans MW, van Meijel B, Dekker J, Syrjala KL. Developing a Risk Prediction Model for Long-Term Physical and Psychological Functioning after Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2016 Mar;22(3):549-56. doi: 10.1016/j.bbmt.2015.11.1102. Epub 2015 Dec 11.

    PMID: 26685773BACKGROUND
  • Fasching PA, Thiel F, Nicolaisen-Murmann K, Rauh C, Engel J, Lux MP, Beckmann MW, Bani MR. Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies. Support Care Cancer. 2007 Nov;15(11):1277-1284. doi: 10.1007/s00520-007-0231-1. Epub 2007 Mar 1.

    PMID: 17333294BACKGROUND
  • Garcia MK, McQuade J, Haddad R, Patel S, Lee R, Yang P, Palmer JL, Cohen L. Systematic review of acupuncture in cancer care: a synthesis of the evidence. J Clin Oncol. 2013 Mar 1;31(7):952-60. doi: 10.1200/JCO.2012.43.5818. Epub 2013 Jan 22.

    PMID: 23341529BACKGROUND
  • Lee A, Chan SK, Fan LT. Stimulation of the wrist acupuncture point PC6 for preventing postoperative nausea and vomiting. Cochrane Database Syst Rev. 2015 Nov 2;2015(11):CD003281. doi: 10.1002/14651858.CD003281.pub4.

    PMID: 26522652BACKGROUND
  • Shneerson C, Taskila T, Gale N, Greenfield S, Chen YF. The effect of complementary and alternative medicine on the quality of life of cancer survivors: a systematic review and meta-analyses. Complement Ther Med. 2013 Aug;21(4):417-29. doi: 10.1016/j.ctim.2013.05.003. Epub 2013 Jun 3.

    PMID: 23876573BACKGROUND
  • Sun CL, Francisco L, Baker KS, Weisdorf DJ, Forman SJ, Bhatia S. Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS). Blood. 2011 Oct 27;118(17):4723-31. doi: 10.1182/blood-2011-04-348730. Epub 2011 Aug 5.

    PMID: 21821714BACKGROUND
  • Saramago P, Woods B, Weatherly H, Manca A, Sculpher M, Khan K, Vickers AJ, MacPherson H. Methods for network meta-analysis of continuous outcomes using individual patient data: a case study in acupuncture for chronic pain. BMC Med Res Methodol. 2016 Oct 6;16(1):131. doi: 10.1186/s12874-016-0224-1.

    PMID: 27716074BACKGROUND
  • Witt CM, Pach D, Brinkhaus B, Wruck K, Tag B, Mank S, Willich SN. Safety of acupuncture: results of a prospective observational study with 229,230 patients and introduction of a medical information and consent form. Forsch Komplementmed. 2009 Apr;16(2):91-7. doi: 10.1159/000209315. Epub 2009 Apr 9.

    PMID: 19420954BACKGROUND
  • Fuentealba Cargill F, Biagini Alarcon L. [Acupuncture for postoperative pain, a literature review]. Rev Med Chil. 2016 Mar;144(3):325-32. doi: 10.4067/S0034-98872016000300007. Spanish.

    PMID: 27299818BACKGROUND

MeSH Terms

Conditions

Hematologic NeoplasmsGraft vs Host DiseaseDepressionLeukemia

Interventions

HealthAcupuncture Therapy

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsHematologic DiseasesHemic and Lymphatic DiseasesImmune System DiseasesBehavioral SymptomsBehaviorNeoplasms by Histologic Type

Intervention Hierarchy (Ancestors)

Population CharacteristicsComplementary TherapiesTherapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. med.

Study Record Dates

First Submitted

November 21, 2016

First Posted

November 29, 2016

Study Start

December 1, 2016

Primary Completion

December 16, 2019

Study Completion

December 16, 2019

Last Updated

December 18, 2019

Record last verified: 2019-12

Locations